BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 23872790)

  • 1. Patient-reported hereditary breast and ovarian cancer in a primary care practice.
    Quillin JM; Krist AH; Gyure M; Corona R; Rodriguez V; Borzelleca J; Bodurtha JN
    J Community Genet; 2014 Apr; 5(2):179-83. PubMed ID: 23872790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
    ; Owens DK; Davidson KW; Krist AH; Barry MJ; Cabana M; Caughey AB; Doubeni CA; Epling JW; Kubik M; Landefeld CS; Mangione CM; Pbert L; Silverstein M; Simon MA; Tseng CW; Wong JB
    JAMA; 2019 Aug; 322(7):652-665. PubMed ID: 31429903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and healthcare actions of women in a large health system with a family history meeting the 2005 USPSTF recommendation for BRCA genetic counseling referral.
    Bellcross CA; Leadbetter S; Alford SH; Peipins LA
    Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):728-35. PubMed ID: 23371291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRCA-Related Cancer Genetic Counseling is Indicated in Many Women Seeking Primary Care.
    Parente DJ
    J Am Board Fam Med; 2020; 33(6):885-893. PubMed ID: 33219067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.
    Moyer VA;
    Ann Intern Med; 2014 Feb; 160(4):271-81. PubMed ID: 24366376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization and Outcomes of BRCA Genetic Testing and Counseling in a National Commercially Insured Population: The ABOUT Study.
    Armstrong J; Toscano M; Kotchko N; Friedman S; Schwartz MD; Virgo KS; Lynch K; Andrews JE; Aguado Loi CX; Bauer JE; Casares C; Bourquardez Clark E; Kondoff MR; Molina AD; Abdollahian M; Walker G; Sutphen R
    JAMA Oncol; 2015 Dec; 1(9):1251-60. PubMed ID: 26426480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring Predictors of Genetic Counseling and Testing for Hereditary Breast and Ovarian Cancer: Findings from the 2015 U.S. National Health Interview Survey.
    Allen CG; Roberts M; Guan Y
    J Pers Med; 2019 May; 9(2):. PubMed ID: 31083288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognizing BRCA gene mutation risk subsequent to breast cancer diagnosis in southwestern Ontario.
    Vanstone M; Chow W; Lester L; Ainsworth P; Nisker J; Brackstone M
    Can Fam Physician; 2012 May; 58(5):e258-66. PubMed ID: 22734169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence Patterns to National Comprehensive Cancer Network Guidelines for Referral of Women With Breast Cancer to Genetics Professionals.
    Stuckey A; Febbraro T; Laprise J; Wilbur JS; Lopes V; Robison K
    Am J Clin Oncol; 2016 Aug; 39(4):363-7. PubMed ID: 24710121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Too many referrals of low-risk women for BRCA1/2 genetic services by family physicians.
    White DB; Bonham VL; Jenkins J; Stevens N; McBride CM
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):2980-6. PubMed ID: 18990739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Nelson HD; Pappas M; Cantor A; Haney E; Holmes R
    JAMA; 2019 Aug; 322(7):666-685. PubMed ID: 31429902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers and facilitators to BRCA genetic counseling among at-risk Latinas in New York City.
    Sussner KM; Jandorf L; Thompson HS; Valdimarsdottir HB
    Psychooncology; 2013 Jul; 22(7):1594-604. PubMed ID: 22987526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reported referral for genetic counseling or BRCA 1/2 testing among United States physicians: a vignette-based study.
    Trivers KF; Baldwin LM; Miller JW; Matthews B; Andrilla CH; Lishner DM; Goff BA
    Cancer; 2011 Dec; 117(23):5334-43. PubMed ID: 21792861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why Is Cancer Genetic Counseling Underutilized by Women Identified as at Risk for Hereditary Breast Cancer? Patient Perceptions of Barriers Following a Referral Letter.
    Kne A; Zierhut H; Baldinger S; Swenson KK; Mink P; Veach PM; Tsai ML
    J Genet Couns; 2017 Aug; 26(4):697-715. PubMed ID: 27826805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Clinical Genetics Attendance at a Gynecologic Oncology Tumor Board on Referrals for Genetic Counseling and BRCA Mutation Testing.
    Cohen PA; Nichols CB; Schofield L; Van Der Werf S; Pachter N
    Int J Gynecol Cancer; 2016 Jun; 26(5):892-7. PubMed ID: 27051053
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.